The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
Key Information |
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
Trading Details |
Distributions |
Taxes |
NAV | Daily Change | |||
Market Price | Daily Change |
Fund NAV | Market Price | Index | |
---|---|---|---|
Options Details |
Net Assets (%) | Ticker | Name | SEDOL | Shares Held | Market Value |
---|---|---|---|---|---|
Exposure |
ETF Characteristics |
ETF Risk Stats |
NAV | $9.17 | Daily Change | $0.21 | 2.34% |
Market Price | $9.13 | Daily Change | $0.22 | 2.47% |
VERSUS | BETA |
---|---|
S&P 500 | 1.20 |
NASDAQ-100 | 0.85 |
MSCI EAFE | 1.12 |
MSCI Emg. Mkts | 0.92 |
Standard Deviation | 26.40% |
Return on Equity | 7.00% | |
Weighted Avg. Market Cap | 11,504 M | |
2024 | 2025 | |
Price-to-earnings | -456.36 | 57.04 |
Price-to-book value | 4.19 | 3.85 |
Sector | Weight (%) | |
---|---|---|
Health Care | 91.9 | |
Materials | 3.8 | |
Financials | 3.6 | |
Consumer Staples | 0.8 |
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
5.23 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 26.71 | 64,777 | 1,730,193.67 |
4.91 | TMDX | TRANSMEDICS GROUP INC | BK6TM04 | 92.25 | 17,616 | 1,625,076.00 |
4.55 | PME AU | PRO MEDICUS LTD | 6292782 | 133.75 | 11,263 | 1,506,469.02 |
4.46 | MASI | MASIMO CORP | B1YWR63 | 157.93 | 9,337 | 1,474,592.41 |
4.38 | DXCM | DEXCOM INC | B0796X4 | 66.86 | 21,676 | 1,449,257.36 |
4.30 | VEEV | VEEVA SYSTEMS INC-CLASS A | BFH3N85 | 220.53 | 6,447 | 1,421,756.91 |
4.27 | DOCS | DOXIMITY INC-CLASS A | BMD22Y4 | 54.22 | 26,033 | 1,411,509.26 |
4.21 | PODD | INSULET CORP | B1XGNW4 | 246.49 | 5,653 | 1,393,407.97 |
4.21 | PHIA NA | KONINKLIJKE PHILIPS NV | 5986622 | 24.54 | 56,726 | 1,391,977.98 |
4.17 | ISRG | INTUITIVE SURGICAL INC | 2871301 | 487.93 | 2,827 | 1,379,378.11 |
Holdings are subject to change. "Cash" denotes U.S. dollars.
As of recent month & quarter-end (Mar 31 2025) | Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | -1.26% | -0.63% | -0.61% |
3 Years | -13.44% | -13.38% | -13.05% |
Since Inception | -9.74% | -9.70% | -9.29% |
The Fund’s investment objective and investment strategies changed effective April 1, 2025. Index performance (noted as "Index" above in the chart) reflects the performance of the Solactive Telemedicine & Digital Health Index prior to April 1, 2025 and the Global X HealthTech Index thereafter.
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.